QSS
DCPH

Quantitative Systematic Strategies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Quantitative Systematic Strategies’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,724
Closed -$288K – 759
2017
Q4 		$288K Buy
+12,724
New +$249K 0.07% 397

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Quantitative Systematic Strategies's DCPH Position: Q1 2018 in Review

Quantitative Systematic Strategies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2018, closing a stake of 12,724 shares — an estimated $288K sold.

Quantitative Systematic Strategies first reported a position in DCPH in Q4 2017 and held it in 1 quarter. The position peaked at $288K in Q4 2017. 55 funds tracked by Wall St. Rank hold DCPH as of Q1 2018.

  • Quantitative Systematic Strategies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 12,724 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2018, an estimated $288K.
  • Quantitative Systematic Strategies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $288K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2018, filed 4 May 2018.